Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-01

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

What is this study about? We are studying whether the Pleth Variability Index (PVI)-a simple, non-invasive measurement from a pulse oximeter-can help predict low blood pressure (hypotension) during routine maintenance hemodialysis. Low blood pressure during dialysis is a common and potentially serious complication. Our goal is to find out if monitoring PVI can help identify patients at risk, so that early action can be taken.

Who can join? Adults aged 18 to 80 years. Patients who have been receiving maintenance hemodialysis regularly for more than 3 months.

Those who are willing and able to participate and sign an informed consent form.

Who cannot join? Patients with severe heart rhythm problems, severe peripheral circulation problems, or swelling that makes PVI measurement unreliable.

Patients who are pregnant or breastfeeding. Patients allergic to the dialysis filter or unable to cooperate with the study procedures.

What will happen during the study? PVI Measurement: Your PVI will be checked with a simple fingertip device before starting dialysis and again 30 minutes after dialysis begins.

Blood Pressure Monitoring: Your blood pressure will be closely watched throughout the dialysis session.

Data Collection: Information about your age, medical history, medications, lab results, dialysis settings, and other standard measurements will be recorded.

What are the benefits and risks? Benefits: By identifying patients at higher risk for low blood pressure during dialysis, the study may lead to safer and more comfortable dialysis treatment in the future.

Risks: All measurements used in this study are safe and non-invasive, with no extra risk compared to routine care.

Your Rights and Safety Participation is completely voluntary-you may leave the study at any time without affecting your medical care.

The study has been reviewed and approved by the hospital's ethics committee. Your privacy and personal data will be strictly protected.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension

NCT07033260

Intradialytic Hypotension End-Stage Renal Disease Requiring Haemodialysis Uremia; Chronic +1 more

RECRUITING

Inferior Vena Cava Collapsibility Index and Intradialytic Hypotension

NCT07033273

End-Stage Renal Disease Requiring Haemodialysis Intradialytic Hypotension

RECRUITING

Using a Hypotension Prediction Index to Prevent Low Blood Pressure During Dialysis in ICU Patients

NCT07179705

Intradialytic Hypotension Intensive Care Unit ICU Hemodialysis Patients

RECRUITING NA

Orthostatic Hypotension and Blood Pressure Variability in Persons Undergoing Hemodialysis

NCT06348589

Chronic Kidney Disease Requiring Chronic Dialysis

COMPLETED

Interest of Urinary Oxygen Partial Pressure (PO2u) in Predicting the Onset or Recovery of Acute Renal Failure During Shock States - OXYpi Study

NCT06320509

Shock Circulatory

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypotension and Shock Hemodialysis End-Stage Renal Disease Requiring Haemodialysis Intradialytic Hypotension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Maintenance Hemodialysis Patients

Adult patients aged 18 to 80 years who have been receiving maintenance hemodialysis for more than 3 months. All participants will be monitored for blood pressure and Pleth Variability Index (PVI) measurements before and during hemodialysis sessions. The occurrence of intradialytic hypotension and its association with PVI will be evaluated.

Non-invasive Monitoring

Intervention Type OTHER

All participants will undergo non-invasive measurement of Pleth Variability Index (PVI) and routine blood pressure monitoring before and during hemodialysis sessions. No treatment or experimental intervention will be applied.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-invasive Monitoring

All participants will undergo non-invasive measurement of Pleth Variability Index (PVI) and routine blood pressure monitoring before and during hemodialysis sessions. No treatment or experimental intervention will be applied.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 18 to 80 years.
* Diagnosis of end-stage renal disease and undergoing maintenance hemodialysis for more than 3 months.
* Able and willing to provide informed consent and comply with study procedures.

Exclusion Criteria

* Severe cardiac arrhythmias or significant peripheral vascular disease that may interfere with PVI measurements.
* Local edema, skin lesions, or other conditions that prevent accurate PVI monitoring.
* History of hemodynamic instability unrelated to dialysis.
* Pregnant or breastfeeding women.
* Known allergy or contraindication to materials used in the hemodialysis circuit.
* Unable to cooperate with study procedures.
* Participation in another interventional clinical study within the past 30 days.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No